Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity
Oefner, C., Bandera, M., Haldimann, A., Laue, H., Schulz, H., Mukhija, S., Parisi, S., Weiss, L., Lociuro, S., Dale, G.E.(2009) J Antimicrob Chemother 63: 687-698
- PubMed: 19211577 
- DOI: 10.1093/jac/dkp024
- Primary Citation of Related Structures:  
3FRA, 3FRB, 3FRD, 3FRE, 3FRF - PubMed Abstract: 
Iclaprim is a novel 2,4-diaminopyrimidine that exhibits potent, rapid bactericidal activity against major Gram-positive pathogens, including methicillin-susceptible Staphylococcus aureus and methicillin-resistant S. aureus, and is currently in clinical development for the treatment of complicated skin and skin structure infections ...